S
Shanghai Hanhong Technology
Pharmaceutical building blocks, intermediates, and API manufacturing services
About Shanghai Hanhong Technology
Shanghai Hanhong Technology Co., Ltd., established in 2003 and headquartered in Shanghai, is a high-tech enterprise specializing in the biomedical field. The company focuses on the research, development, and production of drug molecular building blocks, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). It also provides integrated Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, guiding products from molecular blocks to APIs.
The company's core business revolves around three main areas: advanced chemical reagents (primarily building blocks), APIs and intermediates, and custom synthesis. Hanhong Technology has developed significant technical expertise in biocatalysis, chiral chemistry, and green synthesis. Its product portfolio includes a strong focus on unnatural amino acids, protected amino acids, and their derivatives, where it holds a significant market share. The firm operates a 2,200-square-meter R&D center in Fengxian, Shanghai, and has established production bases in Binhai (Jiangsu), Gaotang (Shandong), and Lanzhou (Gansu). These facilities are equipped with over 300 reactors with capacities ranging from 10L to 5000L, enabling custom synthesis from gram to ton scale.
Financially, the company is privately held and venture capital-backed, having completed a Series A funding round of $14 million in December 2023 with investors including Jinshan Capital Group and Shengshan Asset Management. As of 2022, Hanhong Technology reported sales revenue of 210 million yuan and employed 150 people. The leadership team includes CEO Ma Shizhong, a biochemical engineer from East China University of Science and Technology, and CFO Zhou Jianping, a certified public accountant with experience in IPO processes.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2023 | $14M | $55M | Jinshuihu Fund · Shengshan Asset Management | ↗ |
Growth signals
Latest recorded traffic for Shanghai Hanhong Technology is 650 monthly website visits, up 75.7% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Hanhong Technology in its local ecosystem
The Shanghai Hanhong Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- JFJinshuihu Fund
Shengshan Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Hanhong Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Hanhong Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.